BEIRUT (Reuters) - The leader of Lebanon's Hezbollah said on Thursday that his group had obtained precision rockets despite Israeli strikes in recent years aimed at cutting the supply route through Syria. "No matter what you do to cut the route, the matter is over and the resistance possesses precision and non-precision rockets and weapons capabilities," Sayyed Hassan Nasrallah said, addressing Israel in a broadcast speech. "If Israel imposes a war on Lebanon, Israel will face a fate and a reality it has never expected on any day," he added. Hezbollah, backed by Iran, has played a critical role in supporting Syrian President Bashar al-Assad during Syria's seven-year-long civil war. Israel regards Hezbollah as the biggest threat on its borders and has said that it has carried out repeated strikes in Syria to prevent it getting arms deliveries from Iran. Iran's Revolutionary Guards helped form Hezbollah in the early 1980s to resist Israel's occupation of southern Lebanon, which ended in 2000. Israel and Hezbollah fought a brief war on Lebanese soil in 2006. (Reporting By Angus McDowall and Laila Bassam; Editing by Toby Chopra, William Maclean)
- Associated Press
Sri Lankan Roman Catholic Church officials declared a “Black Sunday” this weekend to demand justice for the victims of 2019 Easter Sunday bomb attacks that killed more than 260 people. Archbishop of Colombo Cardinal Malcolm Ranjith said Tuesday that the church has been given part of a presidential commission's report into the coordinated suicide bomb attacks on April 21, 2019, but many questions remain about its findings. A power struggle between the then president and prime minister which led to a communications breakdown and a resulting lapse in security coordination is said to have enabled the attacks, which occurred despite prior foreign intelligence warnings.
Fauci said that delaying a second dose to inoculate more Americans creates risks. He warned that shifting to a single-dose strategy for the vaccines could leave people less protected, enable variants to spread and possibly boost skepticism among Americans already hesitant to get the shots. "There's risks on either side," Fauci was quoted as saying by the Washington Post in a report published late on Monday.
- The Daily Beast
DANIEL LEAL-OLIVAS / Getty ImagesPrince Harry and Meghan Markle are being urged by some commentators in the U.K. to ask CBS to postpone the airing of its Oprah Winfrey interview, in which they are expected to mount a stinging attack on the royal family, as concern mounts over Prince Philip’s prospects of beating an infection.Prince Harry Tells Oprah He Left the Royals Because He Feared Meghan Markle Would Suffer Like Princess Diana Philip, 99, was moved to a specialist heart hospital on Monday and royal sources have been quoted by British newspapers saying the family is “pretty appalled” at the idea of the interview, which Oprah has said sees Meghan saying “pretty shocking things” being broadcast while Philip is so unwell.Penny Junor, author of Prince Harry, Brother, Soldier, Son, told The Daily Beast that airing the interview while Prince Philip was undergoing very public health travails risked making the interview look inappropriate, saying: “Anything could hijack this interview. Philip is ill. He is 99 and could die at any time. They were not to know he would get ill, but it could be seen to be the wrong time. But I doubt it is in their gift to postpone the interview. The control is in the hands of CBS and Oprah.”Robert Lacey, historical consultant for The Crown and author of the definitive royal biography Majesty, told The Daily Beast: “I think it would be a marvelous turnaround for Harry’s image if he took the brave step of canceling the whole thing this weekend—or, if that’s not practical, postponing it at least.”Royal commentator and former editor of Who’s Who Richard Fitzwilliams said it would “surely be appropriate” to postpone the interview.He told MailOnline: “Oprah is their friend and neighbor and would undoubtedly comply if asked and the gesture would I am sure be appreciated by the royal family. If an interview has been extended, as this recently has, it can also be postponed, as this undoubtedly should be.” Royal biographer Robert Jobson told the Mail: “With the Duke of Edinburgh clearly very unwell, the fact that the couple plan to go ahead with airing their self-indulgent, no-holds-barred interview with chat show queen Oprah Winfrey makes them appear heartless, thoughtless, and supremely selfish.“For U.S. broadcast network CBS, this interview is a coup, all about securing big viewing figures and big advert sales around the airing of their exclusive interview. So even if they wanted to Harry and Meghan probably couldn’t dictate terms to Oprah Winfrey and the network now. Too much has been invested.”A TV industry insider told the Mirror: “CBS has sold millions of dollars worth of advertising around the interview, but bosses are aware of the delicacy of the Duke’s heath. They have no loyalty to the royal family, although some feel as though they do to Harry and Meghan. For it to run if Philip’s condition worsened would be like setting off a diplomatic bomb. It would be grossly insensitive and hugely disrespectful.”Read more at The Daily Beast.Get our top stories in your inbox every day. Sign up now!Daily Beast Membership: Beast Inside goes deeper on the stories that matter to you. Learn more.
- Charlotte Observer
Grayson Sherrill of Cherryville becomes at least the sixth North Carolinian charged in connection with the Jan. 6 violence in Washington.
- The Telegraph
French doctors have blamed deep domestic scepticism of AstraZeneca on the “bad press” it has received, including criticism from Emmanuel Macron that it was “quasi-ineffective” for the elderly. The indirect criticism of the French president, who was forced to say he would take the jab if necessary last week, came as Gallic health regulators said they would make the jab available for the over 65s. Mr Macron fanned Gallic scepticism over the jab developed by AstraZeneca and Oxford University in January hours before it received a green light from the European Medecines Agency by saying: “Everything points to thinking it is quasi-ineffective on people older than 65, some say those 60 years or older." Since then, French reports of flu-like side-effects among dozens of health workers further tainted its image. That contributed to a dearth of demand in France, where only 24 per cent of AstraZeneca stocks have been used, according to the health ministry. That is well below a target set at 80-85 per cent and compares with 82 per cent for vaccines made by Pfizer/BioNTech and 37 per cent for those made by Moderna. "It is true that we are facing issues with AstraZeneca vaccines," said a health ministry official. The scepticism prompted Jacques Battistoni, head of the MG France doctors' union to denounce the widespread "AstraZeneca bashing" that was causing many vials to go unused. France’s vaccination coordinator, Alain Fischer, has also complained that the "bad press" surrounding the shot was "deeply unfair".
- Associated Press
The United States wasted billions of dollars in war-torn Afghanistan on buildings and vehicles that were either abandoned or destroyed, according to a report released Monday by a U.S. government watchdog. The agency said it reviewed $7.8 billion spent since 2008 on buildings and vehicles. Only $343.2 million worth of buildings and vehicles “were maintained in good condition,” said the Special Inspector General for Afghanistan Reconstruction, or SIGAR, which oversees American taxpayer money spent on the protracted conflict.
From fun fashion moments to pets and "Schitt's Creek" references, here are interesting things you might not have seen during the award show.
- Business Insider Video
When US Airways Flight 1549 landed in the Hudson river all 150 passengers survived. Landing a plane on the water is called ditching. Ditching is more common in smaller private planes, not large planes from companies like Boeing or Airbus. But the Miracle on the Hudson isn't the only time an aircraft has been ditched. And despite that success, landing a plane on the water can be extremely dangerous.
The European Commission said on Tuesday that it was considering emergency approvals for COVID-19 vaccines as a faster alternative to more rigorous conditional marketing authorisations which have been used so far. The move would mark a big shift in approach to vaccine approvals, as it would entail using a procedure that the EU had considered dangerous and that before the COVID-19 pandemic had been reserved for exceptional authorisation at national level of drugs for terminally ill patients, including cancer treatments. The potential change comes as the EU executive and the bloc's drug regulator come under increasing pressure for what some consider slow vaccine approvals, which have contributed to a slower rollout of COVID-19 shots in the 27-nation union, compared to the United States and former EU member Britain.
Foods that have vitamin D include salmon, rainbow trout, mushrooms, and egg yolks.
- The Daily Beast
Carl Court/GettyBy William G. Bain, Georgios D. Kitsios, and Tomeka L. SuberA year ago, when U.S. health authorities issued their first warning that COVID-19 would cause severe “disruption to everyday life,” doctors had no effective treatments to offer beyond supportive care.There is still no cure, but thanks to an unprecedented global research effort, several treatments are helping patients survive COVID-19 and stay out of the hospital altogether.COVID-19 treatments target two broad problems: the coronavirus’s ability to spread through the body, and the damage caused by the body’s immune system response. When the virus enters the body, it takes over cells and uses them to replicate itself. In response, the body sends inflammatory signals and immune cells to fight the virus. In some patients, that inflammatory response can continue even after the virus is under control, leading to damage in the lungs and other organs.The best tool is prevention, including using face masks and vaccines. Vaccines train the immune system to fight off attackers. With less risk of an uncontrolled infection, they can cut the risk of death from COVID-19 to near zero. But vaccine supplies are limited, even with a third vaccine now authorized for U.S. use, so treatments for infected patients remain crucial.This Drug Is a Staple of COVID Treatment. Should It Be?As doctors who work with COVID-19 patients, we have been following the drug trials and success stories. Here are six treatments commonly used today for COVID-19. As you’ll see, timing matters.Keeping you out of the hospitalTwo promising types of treatments involve injecting antiviral antibodies into high-risk COVID-19 patients before the person becomes severely ill.Our bodies naturally create antibodies to recognize foreign invaders and help fight them off. But natural antibody production takes several days, and SARS-CoV-2—the coronavirus that causes COVID-19—replicates fast. Studies show that injecting patients with antibodies soon after symptoms begin can help protect patients against serious infection.Monoclonal antibodies: These lab-engineered antibodies can bind to SARS-CoV-2 and prevent the virus from entering cells and infecting them. They include Bamlanivimab and the combined therapy casirivimab/imdevimab developed by Regeneron. The U.S. Food and Drug Administration granted emergency use authorization for these therapies because they have been found to protect high-risk patients from hospitalization and death. Once patients are sick enough to need hospitalization, however, studies haven’t found a proven benefit from them.Convalescent plasma: Another way to deliver antibodies involves blood drawn from patients who have recovered from COVID-19. Convalescent plasma is primarily given in research settings because the clinical evidence so far is mixed. Some trials show benefits early in the disease. Other studies have not shown any benefit in hospitalized patients.There may be a role for convalescent plasma as a supplemental therapy for some patients because of the growing threat of mutated SARS-CoV-2 variants, which may evade monoclonal antibody therapy. However, careful research is necessary.If you are hospitalizedOnce patients become so sick that they have to be hospitalized, treatments change.Most hospitalized patients have difficulty breathing and low oxygen levels. Low oxygen occurs when the virus and corresponding immune response injure the lungs, resulting in swelling in lung air sacs that restricts the amount of oxygen getting into the blood. Patients hospitalized with COVID-19 usually need supplemental medical oxygen to help them breathe. Doctors frequently treat patients on oxygen with the antiviral agent remdesivir and anti-inflammatory corticosteroids.Remdesivir: Remdesivir, originally designed to treat hepatitis C, stops the coronavirus from replicating itself by interfering with its genetic building blocks. It has been shown to shorten the length of hospital stays, and doctors may prescribe it to patients on oxygen shortly after arrival in the hospital.Chris Christie Says He’s Out of the Hospital After Week-Long Stay for COVID-19Corticosteroids: Steroids calm the body’s immune response and have been used for decades to treat inflammatory disorders. They are also widely available, cheap and well-studied medications, so they were among the first therapies to enter clinical trials for COVID-19. Several studies have shown that low-dose steroids reduce deaths in hospitalized patients who are on oxygen, including the sickest patients in the intensive care unit, or ICU. Following the findings of the landmark RECOVERY and REMAP-CAP COVID-19 studies, steroids are now the standard of care for patients hospitalized with COVID-19 who are treated with oxygen.Blood thinners: Inflammation during COVID-19 and other viral infections can also increase the risk of blood clots, which can cause heart attacks, strokes and dangerous clots in the lungs. Many patients with COVID-19 are given the blood thinners heparin or enoxaparin to prevent clots before they occur. Early data from a large trial of COVID-19 patients suggests that hospitalized patients benefit from higher doses of blood thinners.Some patients with COVID-19 become so sick that they need an ICU for high levels of oxygen support or a ventilator to help them breathe. There are several therapies available for ICU patients, but ICU patients have not been found to benefit from high doses of blood thinners.Treating the sickest patientsICU patients with COVID-19 are more likely to survive if they receive steroids, studies have found. However, low-dose steroids alone may not be enough to curb excessive inflammation.Tocilizumab: Tocilizumab is a lab-generated antibody that blocks the interleukin-6 pathway, which can cause inflammation during COVID-19 and other diseases. New results from the REMAP-CAP trial that have not yet been peer-reviewed suggest that a single dose of tocilizumab given within one to two days after being placed on respiratory support reduced the risk of death in patients already receiving low-dose steroids. Tocilizumab has also been shown to benefit patients with high levels of inflammation in early results from another trial.These innovative therapies can help, but careful supportive care in the ICU is also crucial. Decades of extensive research have defined core management principles for helping patients with severe lung infections who need ventilators. These include avoiding underinflation and overinflation of the lung by the ventilator, treating pain and anxiety with low levels of sedative medications, and periodically placing certain patients with low oxygen levels on their belly, among many other interventions. The same key principles likely apply to patients with COVID-19 to help them survive and recover from a critical illness that can last weeks or months.Medical progress since the start of the pandemic has been awe-inspiring. Doctors now have vaccines, antiviral antibodies for high-risk outpatients and several treatments for hospitalized patients. Continued research will be crucial to improve our ability to fight a disease that has already claimed more than 2.5 million lives worldwide.William G. Bain, Georgios D. Kitsios, and Tomeka L. Suber are assistant professors of medicine at the University of PittsburghRead more at The Daily Beast.Get our top stories in your inbox every day. Sign up now!Daily Beast Membership: Beast Inside goes deeper on the stories that matter to you. Learn more.
These looks are so good they're worth repeating.
The Senate Finance Committee said its members will vote on Wednesday on three Biden administration nominees, including Katherine Tai as trade czar and California Attorney General Xavier Becerra as U.S. health secretary. Senate Finance Committee Chair Ron Wyden will convene the business meeting at 10 a.m. to vote on the nominations of Tai, Becerra and Wally Adeyemo, who was nominated as to be deputy Treasury secretary, the committee said. All three candidates are expected to win approval by the committee, a congressional aide said, which would clear the way for their consideration by the full Senate.
- Business Insider
Alexandria Ocasio-Cortez shoots back at Ted Cruz, saying he treated storm-hit Texas as a 'layover' between trips to Cancun and CPAC
"It appears Texas was just a layover stop for him between Cancun and Orlando to drop a pack of water into someone's trunk," Ocasio-Cortez said.
- Associated Press
About 300 student activists rallied in Bangladesh’s capital on Monday to denounce the death in prison of a writer and commentator who was arrested last year on charges of violating a sweeping digital security law that critics say chokes freedom of expression. The protesters marched through the Dhaka University campus and Dhaka's streets toward the country’s Home Ministry to also demand the annulment of the digital security law and the release of seven student activists arrested during recent protests denouncing the death of 53-year-old Mushtaq Ahmed.
Louis Nix's family confirmed his death after officials found his vehicle in a retention pond near his Jacksonville apartment on Saturday.
- The Independent
The Utah senator was visiting his grandchildren over the weekend when he fell
- Associated Press
The Philippine president has dismissed his former ambassador to Brazil after she was seen on video physically abusing a Filipino member of her household staff. President Rodrigo Duterte said Monday night he had approved a recommendation to fire Marichu Mauro, revoke her retirement benefits and disqualify her from public office for life. The Department of Foreign Affairs in Manila said at the time that the unidentified victim had returned to Philippines and that it was trying to reach her amid an investigation.
- Business Insider
The White House says it never wants an assassination like Khashoggi's again, but won't punish MBS for ordering the killing
Biden's White House has essentially leaned on the importance of the diplomatic relationship with Saudi Arabia in defense of its actions.
Throughout its 94 episodes across six seasons, "Sex and the City" featured some very famous faces. The show is now getting a revival on HBO Max.